Portasystemic shunt fraction quantification with colonic iodine-123 iodoamphetamine

Area of Science:

• Nuclear medicine
• Veterinary diagnostics
• Medical imaging

Background:

• Portasystemic shunting is a condition where blood bypasses the liver, leading to toxin accumulation.
• Accurate quantification of shunt fraction is crucial for diagnosis and treatment planning.
• Current methods may be invasive or lack precision.

Purpose of the Study:

• To develop and validate a simple, noninvasive method for quantifying portasystemic shunt fraction.
• To assess the utility of transrectally administered [123I]iodoamphetamine (IMP) for this purpose.
• To compare the novel method with a standard technique.

Main Methods:

• [123I]iodoamphetamine (IMP) was administered transrectally into the colon of dogs and monitored with a gamma camera.
• Pharmacokinetic data of IMP absorption and liver extraction were analyzed.
• Computer simulations were used to model the biological system and quantify shunt fraction.
• Results were compared to 99mTc-labeled macroaggregated albumin infusion.

Main Results:

• IMP was rapidly and unchanged absorbed from the colon.
• The liver demonstrated high first-pass extraction of IMP, with a washout half-life of approximately 60 minutes.
• A simplified model assuming tracer behavior like microspheres showed insignificant error.
• Excellent correlation was observed between the IMP method and the standard technique across all shunt fractions (0-100%).

Conclusions:

• Transrectal administration of [123I]iodoamphetamine (IMP) provides a simple and noninvasive method for quantifying portasystemic shunt fraction in dogs.
• This approach demonstrates high accuracy and excellent correlation with established methods.
• The technique holds potential for routine clinical application in veterinary diagnostics.